Research Article - Biomedical Research (2020) Volume 31, Issue 4

Alteration of haematological parameters among patients with dengue infection.

Kotepui M¹, PhunPhuech B², Phiwklam N², Pokakorn W³, Kotepui KU^1*

¹School of Allied Health Sciences and Public Health, Walailak University, Nakhon Si Thammarat 80161, Thailand

²Medical Technology Laboratory, PhopPhra Hospital, Tak Province 63160, Thailand

³Digital Technology Center, Walailak University, Nakhon Si Thammarat 80161, Thailand

*Corresponding Author:

Kwuntida Uthaisar Kotepui
Medical Technology Program
School of Allied Health Sciences
Walailak University
Nakhon Si Thammarat, Thailand

Accepted date: July 04, 2020

Abstract

Background: The objective of the present study was to evaluate the haematological parameters as screening markers for differentiating patients with dengue fever, and non-dengue fever. Methods: This study was a retrospective case-control study in Tak Province, Thailand. All data of patients suspected with dengue infection during January 2013 and December 2015 were retrieved anonymously from computerized medical records included demographic data, medical history, and laboratory results. For statistical analysis, a normal distribution of continuous data was determined using the Kolmogorov-Smirnov test. Continuous variables were compared using the Mann-Whitney U test. Continuous variables were categorized following laboratory or usual cut-off values. Categorical variables were analyzed using Fisher’s exact test or chi-square test. All analysis was performed by SPSS v.11.5 Chicago: SPSS Inc. Results: The result showed that among 376 suspected patients with dengue infection, WBCs, neutrophils, monocytes, eosinophil’s, MCV, and MCH were significantly lower in patients with DF as compared to patients with non-dengue (p value<0.05). RBCs count were significantly higher in patients with dengue infection (4.99 × 106 /µL vs. 4.91 × 106 /µL; p value=0.039). Platelets count were significantly lower in the patient with dengue infection compared to patients with non-dengue infection (75,000 × 103 /µL vs. 86,000 × 103 /µL; p value=0.042). Conclusion: Alteration of haematological parameters can combine with other clinical and laboratory markers which will help physicians to early diagnosis of dengue fever on the first day of admission to help closely monitoring patients with dengue and prevent developing dengue haemorrhagic fever (DHF).

Keywords

Dengue, Haematological parameters, Markers

Introduction

Dengue fever (DF) is caused by one of the four serotypes of the dengue virus including DEN-1, DEN-2, DEN-3, and DEN-4. This virus is an arbovirus or arthropod-borne viruses that belong to the genus Flavivirus of the family Flaviviridae [1,2]. Dengue have a variety of presentations, ranging from asymptomatic to an undifferentiated fever (dengue fever, DF) to the more severe forms such as dengue haemorrhagic fever (DHF) [3]. According to estimates of the World Health Organization (WHO), about 50 million cases of DF occur annually worldwide and 2.5 billion people live in risk areas [4].

Nowadays, laboratory techniques to confirm dengue infection are detection of viral nucleic acid and viral antigens/antibodies. The detection depends on phase of illness. At the beginning of the illness, the virus can be detected in serum, plasma, circulating blood cells and other tissues for 4-5 days. This onset of illness, virus isolation, and nucleic acid testing or antigen detection can be performed to diagnose the dengue infection [5,6]. In routine screening test of dengue, a rapid dipstick test of Dengue non-structural protein 1 antigen (NS1 Ag) Strip will serve as a useful diagnostic tool [7]. NS1 Ag, a highly conserved non-structural glycoprotein secreted by virusinfected cells, was found to increase during the acute phase of DF infection [8]. Other than antigen detection, at the end of the acute phase of infection, antibody detection is the method of choice for diagnosis [6]. However, antibody detection may take several days [9].

A previous study has showed that leukopenia is the most prominent haematological change with counts of less than 2 × 103 /μL [10]. Moreover, thrombocytopenia can occurred in 88% of the cases [10]. The decreasing platelet counts have found to predict the severity of the disease and were associated with increased haematocrit, increased liver enzymes, altered coagulation profile [11]. Early distinction between dengue and non-dengue could help clinicians to identify patients who should be closely monitored for signs of DHF because of only patients with severe DF and DHF cases should be hospitalized. The objective of the present study was to evaluate the haematological parameters as screening markers for patients who come to the hospital for dengue diagnosis. This will help identify patients with dengue fever from non-dengue fever in order to could help the physician in better management of those patients.

Materials and Methods

The protocol of this study were followed the methods of Kotepui et al. In brief, a retrospective case-control study designed to differentiate between dengue and non-dengue was performed between January 2013 and December 2015 at the Medical Technology Laboratory of PhopPhra Hospital, Tak Province, Thailand.In brief, all data of patients suspected with dengue infection were retrieved anonymously from computerized medical records included demographic data, medical history, and laboratory results. The diagnosis of dengue was based on NS₁ Ag detection and indirect diagnosis based on the detection of specific anti-dengue immunoglobulin M (IgM) or immunoglobulin G (IgG) antibodies in patients’ sera 12.EDTA blood were collected and analyzed to determine the complete blood counts (CBCs) using a BC-5200 Haematology Analyzer (Mindray, Nanshan, Shenzhen, China). Analyzer provided RBC count, haemoglobin (Hb), haematocrit (Hct), platelet count, WBC count, neutrophil, monocyte, lymphocyte and eosinophil counts, mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), and mean corpuscular haemoglobin concentration (MCHC).

For statistical analysis, a normal distribution of continuous data was determined using the Kolmogorov-Smirnov test. Continuous variables were compared using the Mann-Whitney U test. Continuous variables were categorized following laboratory or usual cut-off values. Categorical variables were analysed using the Fisher’s exact test or chi-square test. Statistical significance was set at p value less than 0.05.

Results and Discussion

Demographic data of the study population

The 376 suspected patients with dengue infection were investigated (Table 1).Two hundred and thirty eight patients were confirmed with dengue infection whereas 138 patients were non-dengue infection. The rate of dengue infection among those patients was 63.3%. Median age of patients’ infected and non-infected with dengue was 14 years and 15 years, respectively. Among patients infected with dengue, Thai patients (76.1%) were frequently infected with dengue than non-Thai (23.9%). No significant of age, gender, and nationality were found between the two groups (p value=0.452).

Table 1. General characteristics.

Haematological values of the study population

Several haematological parameters were significantly changed in patients with dengue as compared to patients with nondengue (Table 2). For leukocyte parameters, WBCs, neutrophil, monocyte, and eosinophil count were significantly lower in patients with DF as compared to patients with nondengue (p value<0.01). For red blood cell (RBC) parameters, MCV and MCH were significantly lower than patients with non-dengue (p value<0.05). RBCs count were significantly higher in patients with dengue infection than patients with non-dengue infection (4.99 × 10⁶ /μL vs. 4.91 × 10⁶ /μL; p value=0.039). For platelets count in patient with dengue infection, it were significantly lower than patients with non-dengue infection (75,000 × 10 3 /μL vs. 86,000 × 103/μL; p value=0.042). However, basophils, NL ratio, ML ratio, haemoglobin, haematocrit, MCHC, and were not significantly difference in patients with dengue compared to patients with non-dengue (p value>0.05).

Table 2. Haematological values in study population.

In the present study DF was more common in females (55.5%). This is in accordance with a study in Delhi, India indicated that Dengue seropositive was found to be significantly associated with the female gender [10-12]. However, general studies both sexes are equally affected although a male to female ratio of 0.65:1 [13]. Some studies found twice the number of male patients infected with dengue compared to females [14,15].

DF was more common among the paediatric age group the largest proportion was seen in the age group of 9-25 years. This was in accordance with previous reports in Thailand indicated that the age group with the highest incidence changed from those aged 5-9 years to those over 15 years of age [16-18]. This finding was consistent with the idea that the observed age shift might be a consequence of the demographic transition in Thailand.

This study revealed haematological changes in study population. WBC count was significantly lower in dengue infected patients. This is in accordance with previous studies indicated that patients with dengue had significantly lower white blood cell (WBC) counts [3,19]. This study, neutrophils and lymphocytes counts were significantly lower in DF compared to non-DF. This was in accordance with results of previous studies [3,19-22]. Beside monocytes and eosinophil count were also significantly lower in DF compared to non-DF. This is in accordance with a previous study indicated leukopenia was the most prominent haematological changed during dengue infection [10,19]. Ration of low number of white blood cell and their absolute counts may be due to the reduction in WBC due to bone marrow suppression by dengue virus [23].

This study, lower RBC count, MCV, and MCH in patients with dengue were observed. This never been reported in any previous studies. This could be explained by occurring of haemolyticanaemia in dengue infected patients. However, haemolyticanaemia in dengue fever is considered rare and has been described in case reports in Malaysia, Sri Lanka, India and in a British traveller [24-27].

This study, lower platelet count was observed in patients with dengue compared to non-dengue. This is in accordance with a previous study indicated significantly lower platelet [3]. According to the results, low platelet count is one of the criteria for diagnosis of DHF [5]. The ration behind thrombocytopenia among patients with dengue is currently unknown. However, previous studies indicated decreased production of platelets in DF and increased destruction of platelets in DHF [19,28].

The previous studies indicated that routine laboratory markers help to reduce the cost for laboratory diagnostic screening [20,29]. In routinely diagnosis of dengue infection, dengue non-structural protein 1 antigen (NS1) is an antigen presenting in sera of dengue patients during acute phase of infection and responsible for pathogenesis of dengue [30]. NS1 Ag strip has a rapid, sensitive, and easy to use for the early diagnosis of DF at the presentation [31]. Moreover, several commercial kits available on the market for detecting anti-dengue antibodies such as Immunochromatographic test (IgM/IgG detection) [32,33]. This study found that routine laboratory markers including MCV, neutrophils, MCHC, and lymphocytes are useful in detecting laboratory-confirmed dengue infection. This predictive technique could be used to decide the priority of NS1 Ag strip.

There are several limitations in this study. Firstly, this study was the retrospective and single based-hospital might not reflect the large groups of dengue patients. However, these results may provide useful routine laboratory markers for diagnosing dengue in endemic area,which may help alertness of medical technologist or medical sciences technician performing dengue diagnosis as no single laboratory marker available for predicting DF infection [34].

Conclusion

Alteration of haematological parameters can combine with other clinical and laboratory markers which will help physician to early diagnosis of dengue fever in the first day of admission to help closely monitoring patients with dengue and prevent developing dengue haemorrhagic fever (DHF).

Ethics approval and consent to participate

The retrospective use of anonymous patient files was authorized and approved by the PhopPhra Hospital and the Ethical Clearance Committee on Human Rights Related to Researches Involving Human Subjects of Walailak University. All data collected retrospectively were anonymized in a standardized case report form and in the database. The written informed consent could not be obtained from individual patients as theauthors collected retrospective data from the hospital. In this case, this manuscript, age and sex were not show to hold the anonymity of the patients.

Availability of Data and Materials

The datasets used during the current study are available from the corresponding author based on reasonable request.

Consent for Publication

Not applicable

Competing Interests

The authors declare that there is no conflict of interest regarding the publication of this article.

Funding

This research was partially supported by the new strategic research (P₂P) project, Walailak University, Thailand. The funders had a role in the collection, analysis, and interpretation of the data.

Authors’ Contributions

MK, KK, BP, NP, and WP participated in the study design, data analysis, and writing of the paper. All authors read and approved the final paper.

Acknowledgements

The authors would like to thank all published research that contributed to the data used in this study. The authors are also grateful to Mr. David C. Chang for editing the grammar of this manuscript.

References

1. Anderson CR, Downs WG, Hill AE. Isolation of dengue virus from a human being in Trinidad. Sci 1956; 124: 224-225.
2. Chambers TJ, Hahn CS, Galler R, Rice CM. Flavivirus genome organization, expression, and replication. Ann Rev Microbiol 1990; 44: 649-688.
3. Potts JA, Rothman AL. Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations. Tropical Med Int Health 2008; 13: 1328-1840.
4. W.H.O, Dengue:guidelines for diagnosis, treatment, prevention and control, WHO Press, Geneva, 2009.
5. W.H.O, Dengue Haemorrhagic Fever:Diagnosis, Treatment, Prevention, and Control, WHO, Geneva, 1997.
6. Putnak JR, Kanesa-Thasan N, Innis BL. A putative cellular receptor for dengue viruses. Nature Med 1997; 3: 828-829.
7. Young PR, Hilditch PA, Bletchly C, Halloran W. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J ClinMicrobiol 2000; 38: 1053-1057.
8. Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, Flamand M. Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J CliniMicrobiol 2002; 40: 376-81.
9. Schwartz E, Mileguir F, Grossman Z, Mendelson E. Evaluation of ELISA-based sero-diagnosis of dengue fever in travelers. J ClinicVirol 2000; 19: 169-173.
10. Ageep AK, Malik AA, Elkarsani MS. Clinical presentations and laboratory findings in suspected cases of dengue virus. Saudi Med J 2006; 27: 1711.
11. Phuong CX, Nhan NT, Kneen R, Thuy PT, VanThien CH, Nga NT, Thuy TT, Solomon T, Stepniewska K, Wills B. Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children:is the world health organization classification system helpful. Am J Trop Med Hygie 2004; 70: 172-179.
12. Chakravarti A, Roy P, Malik S, Siddiqui O, Thakur P. A study on gender-related differences in laboratory characteristics of dengue fever. Indian J Med Microbiol 2016; 34: 82.
13. Guha-Sapir D, Schimmer B. Dengue fever:new paradigms for a changing epidemiology. Emerging Themes Epidemiol 2005; 2: 1.
14. Wali JP, Biswas A, Handa R, Aggarwal P, Wig N, Dwivedi SN. Dengue haemorrhagic fever in adults:a prospective study of 110 cases. Tropical Doctor 1999; 29: 27-30.
15. Ray G, Kumar V, Kapoor AK, Dutta AK, Batra S. Status of antioxidants and other biochemical abnormalities in children with dengue fever. J Trop Pediat 1999;45:4-7.
16. M.o.P. Health, Annual Epidemiological Surveillance Report, 2011, 2012.
17. Kongsomboon K, Singhasivanon P, Kaewkungwal J, Nimmannitya S, Jr MM, Nisalak A, Sawanpanyalert P. Temporal trends of dengue fever/dengue hemorrhagic fever in Bangkok, Thailand from 1981 to 2000:An age-period-cohort analysis. Age 2004; 15: 22.
18. Rodríguez-Barraquer I, Buathong R, Iamsirithaworn S, Nisalak A, Lessler J, Jarman RG, Gibbons RV, Cummings DA. Revisiting Rayong:shifting seroprofiles of dengue in Thailand and their implications for transmission and control. Am J Epidemiol 2014; 179: 353-60.
19. Kalayanarooj S, Vaughn DW, Nimmannitya S, Green S, Suntayakorn S, Kunentrasai N, Viramitrachai W, Ratanachu-Eke S, Kiatpolpoj S, Innis BL, Rothman AL. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis 1997; 176: 313-21.
20. Chadwick D, Arch B, Wilder-Smith A, Paton N. Distinguishing dengue fever from other infections on the basis of simple clinical and laboratory features:application of logistic regression analysis. Journal of Clinical Virology. 2006 Feb 1; 35(2): 147-53.
21. Hammond SN, Balmaseda A, Perez L, Tellez Y, Saborío SI, Mercado JC, Videa E, Rodriguez Y, Perez MA, Cuadra R, Solano S. Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua. The Am J Trop Med Hygiene 2005; 73: 1063-1070.
22. Low JG, Ooi EE, Tolfvenstam T, Leo YS, Hibberd ML, Ng LC, Lai YL, Yap GS, Li CS, Vasudevan SG, Ong A. Early Dengue infection and outcome study (EDEN)-study design and preliminary findings. Ann-Acad Med Singapore 2006; 35: 783.
23. Low JG, Ooi EE, Tolfvenstam T, Leo YS, Hibberd ML, Ng LC, Lai YL, Yap GS, Li CS, Vasudevan SG, Ong A. Early Dengue infection and outcome study (EDEN)-study design and preliminary findings. Ann-Acad Med Singapore 2006; 35: 783.
24. Aye M, Cabot J, William LW. Severe Dengue Fever with Haemolytic Anaemia-A Case Study. Trop Med Infect Dis 2016; 1: 6.
25. Medagoda K, de Silva HJ. A case of self-limiting Coomb’s negative haemolytic anaemia following dengue shock syndrome. Ceylon Med J 2011; 48: 4.
26. D Kulkarni, B Sharma, Dengue fever-induced cold-agglutinin syndrome. Therapeutic Advances Infect Dis 2014; 2: 97-9.
27. Radakovic-Fijan S, Graninger W, Müller C, Hönigsmann H, Tanew A. Dengue hemorrhagic fever in a British travel guide. Journal Am Academy Dermatol 2002; 46: 430-433.
28. Cardier JE, Mariño E, Romano E, Taylor P, Liprandi F, Bosch N, Rothman AL. Proinflammatory factors present in sera from patients with acute dengue infection induce activation and apoptosis of human microvascular endothelial cells:possible role of TNF-α in endothelial cell damage in dengue. Cytokine 2005; 30: 359-365.
29. Lee VJ, Lye DC, Sun Y, Fernandez G, Ong A, Leo YS. Predictive value of simple clinical and laboratory variables for dengue hemorrhagic fever in adults. J ClinVirol 2008; 42: 34-39.
30. Hung NT, Lei HY, Lan NT, Lin YS, Huang KJ, Lien LB, Lin CF, Yeh TM, Ha DQ, Huong VT, Chen LC. Dengue hemorrhagic fever in infants:a study of clinical and cytokine profiles. Journal Infect Dis 2004; 189: 221-232.
31. Chaiyaratana W, Chuansumrit A, Pongthanapisith V, Tangnararatchakit K, Lertwongrath S, Yoksan S. Evaluation of dengue nonstructural protein 1 antigen strip for the rapid diagnosis of patients with dengue infection. Diagnostic Microbiol Infect Dis 2009; 64: 83-84.
32. Palmer CJ, King SD, Cuadrado RR, Perez E, Baum M, Ager AL. Evaluation of the MRL diagnostics dengue fever virus IgM capture ELISA and the PanBio Rapid Immunochromatographic Test for diagnosis of dengue fever in Jamaica. J ClinMicrobiol 1999; 37: 1600-1601.
33. Chakravarti A, Gur R, Berry N, Mathur MD. Evaluation of three commercially available kits for serological diagnosis of dengue haemorrhagic fever. Diagnostic Microbiol Infect Dis 2000; 36: 273-274.
34. Thein TL, Gan VC, Lye DC, Yung CF, Leo YS. Utilities and limitations of the World Health Organization 2009 warning signs for adult dengue severity. PLoSNegl Trop Dis 2013; 7: e2023.